MGI PHARMA INC·4

May 26, 2:51 PM ET

MACDONALD JOHN R 4

4 · MGI PHARMA INC · Filed May 26, 2004

Insider Transaction Report

Form 4
Period: 2004-05-26
MACDONALD JOHN R
Sr. VP, Research & Development
Transactions
  • Exercise/Conversion

    Common Stock

    2004-05-26$3.75/sh+3,875$14,53121,213 total
  • Exercise/Conversion

    Common Stock

    2004-05-26$4.75/sh+7,750$36,81317,338 total
  • Exercise/Conversion

    Common Stock

    2004-05-26$3.38/sh+650$2,19421,863 total
  • Sale

    Common Stock

    2004-05-26$63.40/sh16,025$1,016,0175,838 total
  • Exercise/Conversion

    Employee Stock Option - Right to Buy

    2004-05-26$3.75/sh3,875$14,5310 total
    Exercise: $3.75From: 2001-07-01Exp: 2007-07-01Common Stock (3,875 underlying)
  • Exercise/Conversion

    Employee Stock Option - Right to Buy

    2004-05-26$4.75/sh7,750$36,8130 total
    Exercise: $4.75From: 1997-04-29Exp: 2006-04-29Common Stock (7,750 underlying)
  • Exercise/Conversion

    Employee Stock Option - Right to Buy

    2004-05-26$3.38/sh650$2,1940 total
    Exercise: $3.38From: 2001-09-02Exp: 2007-09-02Common Stock (650 underlying)
  • Exercise/Conversion

    Employee Stock Option - Right to Buy

    2004-05-26$4.38/sh3,750$16,4060 total
    Exercise: $4.38From: 2000-01-10Exp: 2006-01-10Common Stock (3,750 underlying)
  • Exercise/Conversion

    Common Stock

    2004-05-26$4.38/sh+3,750$16,4069,588 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    12,330
Footnotes (2)
  • [F1]These shares sold pursuant to a 10(b)5-1 plan filed on February 13, 2004.
  • [F2]Represents shares allocated to reporting person in the MGI PHARMA, INC. Common Stock Fund of the MGI PHARMA, INC. Retirement Savings Plan in its report dated April 30, 2004. The number of shares allocated to the reporting person will vary from time to time based on the relative amounts of stock and cash held in the MGI PHARMA, INC. Common Stock Fund at the time of reporting.

Documents

2 files